| CAS: | 303-26-4 | ||||||||||
| 分子式: | C17H19ClN2 | ||||||||||
| 分子量: | 286.80 | ||||||||||
| 沸点: | 178-180℃ | ||||||||||
| 熔点: | 65-75℃ | ||||||||||
| 中文名称: |
| ||||||||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||||||
| C837962 | MACKLIN | 1-(4-氯二苯甲基)哌嗪 | technical grade, 90 % | 27元/1g; 31元/5g; 72元/25g; 207元/100g; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
储存:室温,干燥 状态:白色到淡黄色固体 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| C1611 | TCI | 1-(4-Chlorobenzhydryl)piperazine | >98.0%(GC) | 280元/1G; 735元/5G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
安全信息
相关法规
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 356308 | J&K | 1-(4-Chlorobenzhydryl)piperazine | 95% | 109元/1G; 155元/5G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0001311 | Meclozine impurity H | European Pharmacopoeia (EP) Reference Standard | 1259.15元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| C24507 | Sigma-Aldrich | 1-(4-Chlorobenzhydryl)piperazine | technical grade, 90% | 469.07元/1 G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| C0980651 | Cetirizine impurity A | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1333058 | USP | Hydroxyzine Related Compound A | United States Pharmacopeia (USP) Reference Standard | 11011.4元/25 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| PHR2872 | Supelco | Hydroxyzine Related Compound A | pharmaceutical secondary standard, certified reference material | 5344.19元/50 mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 068945 | Fluorochem | 1-[(4-Chlorophenyl)(phenyl)methyl]piperazine | >90% | 220元/1g; 396元/5g; 704元/10g; 1298元/25g; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| HY-W001978 | MCE | 1-(4-Chlorobenzhydryl)piperazine,303-26-4_MCE(MedChemExpress) | 165元/10 mM * 1 mL in DMSO; 150元/500 mg; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。 1-(4-Chlorobenzhydryl)piperazineMCE 国际站:1-(4-Chlorobenzhydryl)piperazine 品牌:MedChemExpress (MCE) 货号:HY-W001978 CAS 号:303-26-4 生物活性: 1-(4-氯二苯甲基)哌嗪是一种生化试剂,可用作生命科学相关研究中的生物材料或有机化合物。 体外研究(In Vitro):1-(4-氯苄基)哌嗪是美氯嗪和氯环嗪的无活性代谢物,在羟嗪和西替利嗪的商业制剂中也发现它是一种杂质。1-(4-氯苄基)哌嗪已被用于合成电压门控钠通道 1.7 (Nav1.7) 抑制剂、抗癌剂和抗组胺剂。 MCE尚未独立确认这些方法的准确性。 仅供参考。 分子量:286.80 Formula:C17H19ClN2 性状:固体 颜色:White to off-white 运输条件:美国大陆地区的室温;其他地区可能有所不同。 储存方式:粉末 -20°C 3年 提供质量检测报告:Data Sheet、SDS、COA、HNMR、LCMS、产品使用指南 产品活性:1-(4-Chlorobenzhydryl)piperazine 是一种生化试剂,可作为生物材料或有机化合物,用于生命科学相关研究。 相关产品:3-Butyn-1-ol | 5-Bromouracil | Tetrahydrothiopyran-4-one | 2-Piperazinopyridine | 1-Adamantaneacetic acid | 5-Amino-2-methoxypyridine | 2-Phenylbenzoic acid | 5-Hydroxyanthranilic acid | 3-Hydroxy-1-adamantanecarboxylic acid | 2-Methylbutanoic acid | 4-Amino-TEMPO | 5-Methylindole 热门产品线:抑制剂 | 稳定性同位素标记物 | 脂质 | 糖类 Trending products:Inhibitors | Isotope-Labeled Compounds | Lipids | Saccharides MCE 抑制剂: MedChemExpress 信号通路产品覆盖细胞凋亡、自噬、细胞周期与 DNA 损伤、表观遗传、GPCR/G 蛋白、免疫与炎症、JAK/STAT、MAPK/ERK、膜转运体与离子通道、代谢酶与蛋白酶、神经信号、NF-κB、PI3K/Akt/mTOR、PROTAC、蛋白酪氨酸激酶/受体酪氨酸激酶、干细胞/Wnt、TGF-β/Smad 及维生素 D/核受体等研究方向,为肿瘤、感染、炎症与免疫、神经系统疾病、代谢性疾病、心血管疾病和内分泌研究提供多维度的产品选择,助力客户发表文献超 80,000 篇。 相关产品可根据具体情况提供化学结构、作用靶点、生物活性、纯度、溶解度、体内外研究信息、参考文献及质量分析报告 (COA)等资料。 客户发表文献: 品牌介绍:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||